About NIMBLE Diagnostics
NIMBLE Diagnostics is a company based in Badalona (Spain) founded in 2022 by O'Callaghan JM Spanish, Oriol Rodriguez Leor, Carolina Galvez-Monton, Susana Amoros Garcia De Valdecasas, and Oriol Iborra Egea. NIMBLE Diagnostics has raised $1.08 million across 4 funding rounds from investors including Ship2B, European Union and EIC Fund. NIMBLE Diagnostics offers products and services including NIMBLE System. NIMBLE Diagnostics operates in a competitive market with competitors including Imperative Care, LUMA Vision, Verathon, Deltex Medical and eKuore, among others.
- Headquarter Badalona, Spain
- Founders O'Callaghan JM Spanish, Oriol Rodriguez Leor, Carolina Galvez-Monton, Susana Amoros Garcia De Valdecasas, Oriol Iborra Egea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nimble Diagnostics S.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.08 M (USD)
in 4 rounds
-
Latest Funding Round
$2.65 M (USD), Grant
Oct 31, 2023
-
Investors
Ship2B
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NIMBLE Diagnostics
NIMBLE Diagnostics offers a comprehensive portfolio of products and services, including NIMBLE System.
Non-invasive device for early detection of stent malfunctions in patients.
Funding Insights of NIMBLE Diagnostics
NIMBLE Diagnostics has successfully raised a total of $1.08M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.65 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NIMBLE Diagnostics
NIMBLE Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Ship2B, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Grow Venture Partners is focused on investing in deep tech spin-offs.
|
Locked | Locked | Locked | |
|
Namarel Ventures is focused on health sector startup investments.
|
Locked | Locked | Locked |
Investor details for NIMBLE Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NIMBLE Diagnostics
Investment portfolio details for NIMBLE Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NIMBLE Diagnostics
Detailed financials for NIMBLE Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nimble Diagnostics Comparisons
Peer comparison for NIMBLE Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NIMBLE Diagnostics
NIMBLE Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imperative Care, LUMA Vision, Verathon, Deltex Medical and eKuore, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Access catheters for neurovascular stroke treatment are provided.
|
|
| Locked | Locked | Locked |
Developer of interventional cardiac imaging devices
|
|
| Locked | Locked | Locked |
Medical devices for ultrasound imaging and airway management are developed.
|
|
| Locked | Locked | Locked |
A fluid management and cardiac output monitoring system
|
|
| Locked | Locked | Locked |
Wireless electronic stethoscopes are developed for cardiac anomaly detection.
|
|
| Locked | Locked | Locked |
Ultrathin pressure microcatheters for coronary stenosis diagnosis are developed.
|
Detailed competitors of NIMBLE Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nimble Diagnostics
Complete news archive for NIMBLE Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NIMBLE Diagnostics
NIMBLE Diagnostics was founded in 2022.
NIMBLE Diagnostics is headquartered in Badalona, Spain. It is registered at Badalona, Cataluna, Spain.
Oriol Iborra Egea is the current CEO of NIMBLE Diagnostics. They have also founded this company.
NIMBLE Diagnostics is a funded company, having raised a total of $1.08M across 4 funding rounds to date.
NIMBLE Diagnostics was founded in 2022 in Badalona, Spain, within the medical diagnostics sector. A non-invasive device called the Nimble System is provided by the company to measure and quantify stent malfunctions in cardiovascular conditions. Patients are enabled to be monitored over time, regardless of the stents location, supporting ongoing assessment in clinical settings.
NIMBLE Diagnostics's top competitors include Imperative Care, LUMA Vision and Verathon.
NIMBLE Diagnostics offers NIMBLE System.
NIMBLE Diagnostics has 6 investors. Key investors include Ship2B, European Union, EIC Fund, Grow Venture Partners, and Inveniam Group.